Therapy Areas: Oncology
17 January 2019 - Immuno-oncology company Targovax ASA (OSE:TRVX) revealed on Wednesday the receipt of the European patent that will protect its mutant-RAS specific neoantigen peptides, mutant RAS spe...
17 January 2019 - United States-based Exelixis has received approval from the United States Food and Drug Administration (FDA) for its CABOMETYX (cabozantinib) tablets intended for patients with hepat...
17 January 2019 - France-based Biomunex Pharmaceuticals has signed a licensing agreement with France-based Sanofi.It was reported yesterday that the contract has been signed for the development of bi-...
16 January 2019 - - US-based clinical stage biotechnology company ImmunSYS has added Douglas G. Watson to its board of directors as lead independent director, the company said.

Watson is ...
16 January 2019 - - US-based cancer immunotherapies developer CEL-SCI Corp. (NYSE American: CVM)  has received notification from the staff of the NYSE American, its current listing exchange,...
16 January 2019 - - France-based Pierre Fabre has received updated safety and efficacy results, including mature overall survival, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating th...
Related Headlines